MOLECURE

Live / Registered — Registered (as of 10 Dec 2024)

What this means for you

Registered since 10 Dec 2024. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
97180459
Registration number
7599933
Mark type
Word mark
Filed
20 Dec 2021
Published for opposition
23 May 2023
Registered
10 Dec 2024
Attorney of record
David Orms

Goods and services

  • Class 042 — Scientific and technological services: Medical and pharmacological research services; research and development services in the field of antibodies; research and development services in the field of immunology; research and development in the pharmaceutical and biotechnology fields; drug discovery services; development of pharmaceutical preparations and medicines; research on the subject of pharmaceuticals; conducting clinical trials for others for pharmaceutical products; biological research, clinical research in the field of inflammatory diseases and diseases leading to tissue fibrosis, immunology and cancer, and medical research; medical laboratory services; scientific laboratory services; analysis of human tissues for medical research; laboratory services, namely, laboratory research services, medical laboratory services, scientific laboratory services relating to the production of monoclonal antibodies; medical research and scientific analysis in the field of immunology and antibodies; scientific research for medical purposes in the area of cancerous diseases; biomedical research services; biological research; research relating to biotechnology; clinical research and medical research in the field of inflammatory diseases and diseases leading to tissue fibrosis, immunology and cancer; chemical research and analysis services including analytical services relating to medicines, pharmaceutical preparations and biochemistry; research laboratories, namely, laboratory research in the field of chemistry; scientific and biotechnology research in the field of gene therapy; DNA screening for scientific research purposes; biological research, namely, cell separation research services; research and development services in the field of immunohistology; scientific research in the field of genetics and genetic engineering; consultancy relating to research and development in the field of therapeutics; product custom design and development of medical technology; services for the development of methods of testing, namely, development and establishment of testing specifications and procedures in the field of biotechnology and pharmaceutical fields; conducting technical project studies, namely, technical research in the field of pharmaceutical studies; preparation of project analysis studies, namely, conducting scientific study in the fields of medicine and biotechnology; technical consultancy relating to product development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; advisory services relating to scientific research; providing information about the results of clinical trials for others for pharmaceutical products

Owner

Prosecution history

  • 10 Dec 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 10 Dec 2024 — REGISTERED-PRINCIPAL REGISTER
  • 14 Nov 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 14 Nov 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 14 Nov 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 14 Nov 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 13 Nov 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 10 Oct 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 10 Oct 2024 — NON-FINAL ACTION E-MAILED
  • 10 Oct 2024 — SU - NON-FINAL ACTION - WRITTEN
  • 12 Sept 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 12 Sept 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 12 Sept 2024 — ASSIGNED TO LIE
  • 24 Apr 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 24 Jan 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED

View this trademark record on Marksy